Heron Therapeutics (HRTX) to Release Quarterly Earnings on Thursday

Heron Therapeutics (NASDAQ:HRTX) will likely be announcing its earnings results before the market opens on Thursday, February 27th. Analysts expect the company to announce earnings of ($0.03) per share and revenue of $37.37 million for the quarter.

Heron Therapeutics Stock Up 1.8 %

HRTX opened at $1.72 on Friday. Heron Therapeutics has a 52-week low of $1.04 and a 52-week high of $3.93. The company has a 50 day moving average of $1.65 and a two-hundred day moving average of $1.73. The company has a market cap of $261.61 million, a P/E ratio of -9.56 and a beta of 1.60.

Analyst Ratings Changes

Several research firms recently issued reports on HRTX. StockNews.com cut shares of Heron Therapeutics from a “buy” rating to a “hold” rating in a report on Wednesday, January 29th. Needham & Company LLC reaffirmed a “buy” rating and issued a $4.00 price target on shares of Heron Therapeutics in a report on Wednesday, December 4th.

Heron Therapeutics Company Profile

Heron Therapeutics, Inc, a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration.